Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$13.15 +0.51 (+4.07%)
As of: Sep 30, 2026 · 1:26 PM EDT

Enanta Pharmaceuticals Inc (ENTA) EBIT (2012 - 2026)

Updated

Enanta Pharmaceuticals' EBIT was -$17.24 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$18.89 million a year earlier.

Analysis

Enanta Pharmaceuticals Inc (ENTA) EBIT (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Enanta Pharmaceuticals' EBIT was -$58.73 million through Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -$85.35 million.

  • In earlier fiscal years, EBIT was -$121.69 million in FY2024, -$137.21 million in FY2023, -$123.84 million in FY2022 and -$109.57 million in FY2021.
  • Quarterly EBIT has moved between -$39.45 million (fiscal Q2 2023) and -$11.25 million (fiscal Q1 2026) over five years.
  • Per Business Quant data, ENTA's EBIT in the three fiscal quarters before Q3 2026 was -$11.85 million (Q2 2026), -$11.25 million (Q1 2026) and -$18.39 million (Q4 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.24 Mn
Mar 31, 2026 -11.85 Mn
Dec 31, 2025 -11.25 Mn
Sep 30, 2025 -18.39 Mn
Jun 30, 2025 -18.89 Mn
Mar 31, 2025 -24.53 Mn
Dec 31, 2024 -23.54 Mn
Sep 30, 2024 -29.85 Mn
Jun 30, 2024 -24.19 Mn
Mar 31, 2024 -32.77 Mn
Dec 31, 2023 -34.89 Mn
Sep 30, 2023 -31.03 Mn
Jun 30, 2023 -36.71 Mn
Mar 31, 2023 -39.45 Mn
Dec 31, 2022 -30.01 Mn
Sep 30, 2022 -27.05 Mn
Jun 30, 2022 -32.54 Mn
Mar 31, 2022 -33.85 Mn
Dec 31, 2021 -30.41 Mn
Sep 30, 2021 -33.73 Mn
API Access

Enanta Pharmaceuticals Inc EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ENTA&period=max&api_key=YOUR_API_KEY